Cardiovascular Diabetology

JUNE 20, 2024

Pretransplant type 2 diabetes mellitus (T2DM) is associated with increased cardiovascular and all-cause mortality after heart transplant (HT), but the underlying causes of this association remain unclear.

Heart Transplant 52

Heart Transplant Transplant Diabetes Research 52

The New England Journal of Medicine

FEBRUARY 6, 2025

This report describes the transplantation of a gene-edited porcine kidney in a hemodialysis-dependent man with long-standing diabetes, advanced vasculopathy, and marked dialysis-access challenges.

Kidney Disease 75

Kidney Disease Transplant Diabetes 75

DAIC

FEBRUARY 14, 2025

Led by Mehdi Shishehbor DO, MPH, PhD, interventional cardiologist and a pioneer in the field of limb preservation, the Dodero Center will revolutionize care for patients at risk of losing a leg due to peripheral artery disease and diabetes. For patients with no other options, amputation may become imminent.

Peripheral Arterial Disease 52

Peripheral Arterial Disease Cancer Innovation Best Practices 52

Circulation: Cardiovascular Imaging

JANUARY 15, 2024

BACKGROUND:Advanced chronic kidney disease is associated with high cardiovascular risk, even after kidney transplant. Pretransplant cardiac testing may identify patients who require additional assessment before transplant or would benefit from risk optimization. years post-transplant. A minority had abnormal MPI (n=58, 15%).

Transplant 40

Transplant Coronary Artery Disease Myocardial Infarction Kidney Disease 40

Journal of the American Heart Association

FEBRUARY 29, 2024

BackgroundAnnual heart transplant (HT) volumes have increased, as have post‐HT outpatient care needs. days), and comorbidity burden was high: 42% had hypertension, 38% had diabetes, and 31% had ≥2 comorbidities. Journal of the American Heart Association, Ahead of Print. Length of stay was 3.1 days (interquartile range, 1.6–5.9

Heart Transplant 40

Heart Transplant Transplant Hospital Outpatient 40

Frontiers in Cardiovascular Medicine

JANUARY 18, 2024

However, due to the distinct biological functions of ASCs from different origins or donors with varing health statuses (such as aging, diabetes, or atherosclerosis), the heterogeneity of ASCs deserves more attention. This prompts scientists to select optimal donors for clinical applications.

Heart Disease 64

Heart Disease Myocardial Infarction Transplant Atherosclerosis 64

MIBHS

OCTOBER 31, 2024

Heart Transplant may be considered in severe cases where other treatments have failed. Monitor cholesterol levels and manage conditions like diabetes that can strain the heart. Left Ventricular Assist Device (LVAD) , a mechanical pump that helps the heart pump blood more effectively. Avoid excessive alcohol and drug use.

Blood Pressure 52

Blood Pressure Blood Clot Heart Valves Heart Rhythm 52

Cardiometabolic Health Congress

AUGUST 8, 2024

Cardiometabolic risk encompasses a complex spectrum of interrelated conditions, including cardiovascular disease, type 2 diabetes, and metabolic syndrome. Key contributions: Advanced cardiac imaging (e.g., high-sensitivity troponin, NT-proBNP) in risk stratification Utilization of advanced echocardiographic techniques (e.g.,

Education 59

Education Cardiovascular Disease Diabetes Kidney Disease 59

Dr. Paddy Barrett

MAY 3, 2024

Over half of all ‘healthy’ heart arteries examined before being used for a heart transplant were shown to have evidence of early plaque buildup. It usually takes many years of being exposed to an uncontrolled risk factor such as high blood pressure, high LDL cholesterol or diabetes. The average age of these heart donors?

Heart attacks 105

Heart attacks Heart Attack Blood Pressure Risk Factors 105

DAIC

FEBRUARY 14, 2025

Led by Mehdi Shishehbor DO, MPH, PhD, interventional cardiologist and a pioneer in the field of limb preservation, the Dodero Center will revolutionize care for patients at risk of losing a leg due to peripheral artery disease and diabetes. For patients with no other options, amputation may become imminent.

Hospital 52

Hospital Peripheral Arterial Disease Cancer Innovation 52

Cardiometabolic Health Congress

NOVEMBER 16, 2023

Key findings presented at the conference included disparities in access to kidney transplantation and waitlisting based on race and neighborhood characteristics, racial and ethnic differences in incident chronic kidney disease (CKD), and the use of motivational strategies to improve dialysis nonadherence among African American patients.

Kidney Disease 52

Kidney Disease Blood Pressure Diabetes Hospital 52

Circulation: Heart Failure

JANUARY 16, 2025

However, no biomarker reflecting RVD is available for routine clinical use.METHODS:Proteomic analysis of myocardium from the left ventricle and right ventricle (RV) of patients with heart failure with reduced ejection fraction with (n=10) and without RVD (n=10) who underwent heart transplantation was performed. for both).

Biomarkers 40

Biomarkers Heart Failure Heart Transplant Transplant 40

DAIC

MARCH 5, 2024

“Fluid build-up is challenging to accurately measure today and results in unnecessary hospital admissions due to fluid overload that was not caught early enough to be managed in the home,” said Dr. Nir Uriel , director of advanced heart failure and cardiac transplantation at NewYork-Presbyterian, and principal investigator of the study. “We

Heart Failure 52

Heart Failure Innovation Hospital Technology 52

Cardiology Update

APRIL 9, 2024

STEP-HFpEF DM 5 ( NCT04916470 ) explored the effects of semaglutide in obesity-related HF with preserved ejection fraction (HFpEF) and type 2 diabetes. The primary endpoint was a composite of all-cause mortality, left ventricular assist device (LVAD)/heart transplantation, HF hospitalizations, worsening HF, and KCCQ score changes.

Angina 52

Angina Myocardial Infarction Aortic valve Coronary Artery Disease 52

Dr. Sanjay Gupta

MARCH 6, 2022

These include ACE inhibitors (and now a medication called Entresto), beta blockers, Mineralocorticoid receptor antagonists and now a new class of anti-diabetic medications called SGLT2 inhibitors and ideally wherever possible the patient should try and take a little of all of them as opposed to taking lots of one and none of the others.

Chronic Disease 40

Chronic Disease Quality of Life Heart Failure Nursing 40

Journal of the American Heart Association

MARCH 3, 2025

BackgroundTo analyze the effect of type 2 diabetes (T2D) on cardiorespiratory fitness.MethodsA multilevel model using restricted maximum likelihood method was used to analyze pooled data. Journal of the American Heart Association, Ahead of Print. ResultsAbsolute (cohorts n=30; subjects n=1152; mean difference, 0.29 L/min [95% CI, 0.37

Exercise 45

Exercise Diabetes Bicuspid/Mitral Blood Pressure 45

Circulation

NOVEMBER 11, 2024

All patients were prospectively followed for development of new outcome/cardiac events which included hospitalization for acute HF, CVS-related death, heart transplantation, and also diabetic complications. Circulation, Volume 150, Issue Suppl_1 , Page A4138589-A4138589, November 12, 2024.

Coronary Artery Disease 40

Coronary Artery Disease Diabetes Heart Transplant Tricuspid 40

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Mark Erfe Outcomes of Sutureless/Rapid Deployment Valves Compared to Traditional Bioprosthetic Aortic Valves The Annals of Thoracic Surgery September 2020 J.

Research 52

Research Coronary Artery Bypass Graft Aortic valve Congenital 52

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Hunter Mehaffey 1 Aortic Annular Enlargement in the Elderly: Short and Long-Term Outcomes in the United States The Annals of Thoracic Surgery January 2021 Shinichi Fukuhara 2 Surgical Explant of Transcatheter Aortic Bioprosthesis: Results and Clinical Implications from The Society of Thoracic Surgeons Adult Cardiac Database Analysis Circulation December (..)

Research 52

Research Coronary Artery Bypass Graft Aortic valve Congenital 52

Cardiometabolic Health Congress

MARCH 8, 2024

Anuradha Lala-Trindade, MD: She focuses on the selection and care of patients with mechanical circulatory support devices and heart transplantation, genetic cardiomyopathies, and perioperative management of high-risk cardiac surgical cases.

Cardiac Rehabilitation 59

Cardiac Rehabilitation Academic Diabetes Research 59

Dr. Malcolm Kendrick

OCTOBER 30, 2024

(2022-25) Swiss Reinsurance Company: £645K China Kadoorie Biobank (2002-ongoing) AstraZeneca: $300K Bayer AG: £300K GlaxoSmithKline: £3.6M Elinogrel feasibility trial (2010-2011) Novartis: £500K EMPA-KIDNEY (2017-ongoing) Boehringer Ingelheim: £106.3M Establishing Fuwai-Oxford research centre (2010-ongoing) Merck: £1.1M

Cholesterol 145

Cholesterol Article Research Diet 145